Michelle Frazier Email

SVP Regulatory Affairs . Coya Therapeutics

Current Roles

Employees:
13
Revenue:
$1M
About
The company's proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf' approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson's, Alzheimer's, FTD and autoimmune diseases.
Coya Therapeutics Address
5850 San Felipe St
Houston, TX
United States
Coya Therapeutics Email

Past Companies

Coya Therapeutics, Inc.Senior Vice President Regulatory Affairs
Innovative Global Regulatory Solutions, LLCPresident
CytomX TherapeuticsVice President Regulatory Affairs

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.